Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells
Serigne Lo(The University of Sydney), Yune‐Fang Ueng(National Research Institute of Chinese Medicine)
Cited by 32
Related Papers
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
|EClinicalMedicine|2023|26
MULTIPLE ways to correct for MULTIPLE comparisons in MULTIPLE types of studies
|British Journal of Dermatology|2021|25